Comment in reference to The Consensus on Systemic Arterial Hypertension in Mexico

2017, Number 2

Rev Med Inst Mex Seguro Soc 2017; 55 (2)

Acoltzin-Vidal JRC

Language: Spanish
References: 4
Page: 146
PDF size: 80.38 Kb.

Text Extraction

No abstratc.

REFERENCES

Martín Rosas-Peralta, Silvia Palomo-Piñón, Gabriela Borrayo- Sánchez, Alejandra Madrid-Miller, Eduardo Almeida-Gutiérrez, Héctor Galván-Oseguera et al. Consenso de Hipertensión Arterial Sistémica en México. Rev Med Inst Med Seguro Social. 2016;54(Supl 1):S6-S51.
Acoltzin-Vidal C, Rabling-Arellanos E, Marcial-Gallegos L. Diagnóstico de Hipertensión Arterial basado en el cálculo de la tensión arterial media. Rev Mex Cardiol. 2010;21(3):99-103.
Dahölf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction y hypertension study. (LIFE): A randomized trial against atenolol. Lancet. 2002;356:995-1003.
Hansson L, Zanchetti A, Carruthers G. Dahölf B, Elmfeld D, Julius S et al. The hypertension optimal treatment study. (The HOT study). Blood Press. 1993;3:62-68.